Efficacy of a Multimodal Physiotherapy Program and Mobile-App Guided Meditation in Adults With Frequent or Chronic Tension-Type Headache
JBE-CEF
1 other identifier
interventional
75
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether a multimodal physiotherapy program and guided meditation using a mobile app can help reduce headache pain and improve quality of life in adults with frequent or chronic tension-type headache. The study analyzes the effects of physical and psychological interventions applied both separately and in combination, so that the combined treatment addresses tension-type headache as a multifactorial condition influenced by biopsychophysiological factors, integrating physical and psychological strategies to improve participants' overall well-being. The main questions it aims to answer are:
- Does multimodal physiotherapy lower the intensity and frequency of headaches?
- Does guided meditation through a mobile app help reduce stress and improve emotional well-being?
- Are the combined effects of physiotherapy and meditation greater than either intervention alone? The study will compare:
- A group receiving multimodal physiotherapy sessions once a week for four weeks,
- A group practicing guided meditation with a mobile app for about 5 to 7 minutes daily,
- A group combining both physiotherapy and meditation. Participants will:
- Attend clinical sessions or use the meditation app depending on group assignment,
- Complete short questionnaires about pain, stress, sleep, and daily functioning,
- Record headache episodes in a structured diary during the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
November 26, 2025
November 1, 2025
6 months
November 16, 2025
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in headache pain intensity
Headache pain intensity will be assessed using the Numerical Pain Rating Scale (NPRS, 0-10), where 0 = no pain and 10 = worst imaginable pain. Participants will record NPRS scores for each headache episode in a structured paper headache diary throughout the study (baseline, intervention, and follow-up). Weekly mean NPRS values will be calculated for statistical analysis.
Pre-allocation assessment, Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Secondary Outcomes (10)
Change in headache frequency
Pre-allocation assessment, Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Change in mean headache duration per episode
Pre-allocation assessment, Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Headache Disability Inventory (HDI)
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Headache Impact Test (HIT-6)
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Beck Depression Inventory-II (BDI-II)
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
- +5 more secondary outcomes
Other Outcomes (5)
Number of active and latent myofascial trigger points (TrPs)
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Pressure Pain Thresholds (PPT) using algometry
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
Cervical Range of Motion (CROM device)
Baseline (Week 0), Week 4 (post-treatment), Week 12 (3-month follow-up), Week 24 (6-month follow-up)
- +2 more other outcomes
Study Arms (3)
Multimodal Physiotherapy
EXPERIMENTALParticipants in this group will receive a multimodal physiotherapy program once a week for four weeks. Each session includes thoracic (T4-T7) and cervicothoracic (C7-T1) manipulation, suboccipital inhibition, deep dry needling of the upper trapezius and sternocleidomastoid muscles, specific massage (temporal, paracervical, and SCM muscles), and passive cervical mobilization in rotation and lateral flexion within a pain-free range.
Guided Meditation Group
EXPERIMENTALParticipants in this group will use the Insight Timer mobile application to perform daily guided meditation sessions lasting approximately 5-7 minutes, focused on mindfulness, stress reduction, and sleep improvement. Only free, Spanish-language content from the app will be used. The program will last four weeks.
Combined Multimodal Physiotherapy and Guided Meditation
EXPERIMENTALParticipants in this group will receive both interventions: one weekly session of multimodal physiotherapy for four weeks and daily guided meditation using the Insight Timer app (approximately 5-7 minutes per day).
Interventions
Participants in this group will receive a multimodal physiotherapy program once a week for four weeks. Each session includes thoracic (T4-T7) and cervicothoracic (C7-T1) manipulation, suboccipital inhibition, deep dry needling of the upper trapezius and sternocleidomastoid muscles, specific massage (temporal, paracervical, and SCM muscles), and passive cervical mobilization in rotation and lateral flexion within a pain-free range. All procedures will be performed by a physiotherapist with over ten years of clinical experience.
Participants in this group will use the Insight Timer mobile application to perform daily guided meditation sessions of approximately 5-7 minutes for four weeks. All sessions will use free Spanish-language content focused on mindfulness, stress reduction, and sleep improvement. Participants will receive written instructions to ensure adherence.
Eligibility Criteria
You may qualify if:
- Diagnosis of frequent or chronic tension-type headache (TTH) according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria.
- Ability to understand and communicate in Spanish sufficiently to follow instructions and complete questionnaires.
- Willingness to provide written informed consent and comply with study procedures.
You may not qualify if:
- Diagnosis of migraine or other primary or secondary headache disorders.
- Presence of red flags for manual therapy, including bone pathology, inflammatory disease, malignancy, neurological disorders, vestibular dysfunction, or skin infection in the cervical area.
- Fibromyalgia, pregnancy, or lactation.
- Use of pacemakers or implantable defibrillators.
- Recent medication adjustments, particularly involving psychotropic or chronic pain drugs.
- Severe psychiatric disorders (major depressive episode, bipolar disorder, schizophrenia, or other psychotic conditions).
- Previous physical treatment targeting the cranio-cervical region (manual therapy, dry needling, anesthetic blocks) within the last six months.
- Regular practice of meditation or mindfulness during the last six months.
- Participation in another clinical trial during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
J&R Global Medical Clinic S.L. (NICA 45193)
Granada, 18002, Spain
Related Publications (5)
Fernandez-de-Las-Penas C, Palacios-Cena M, Valera-Calero JA, Cuadrado ML, Guerrero-Peral A, Pareja JA, Arendt-Nielsen L, Varol U. Understanding the interaction between clinical, emotional and psychophysical outcomes underlying tension-type headache: a network analysis approach. J Neurol. 2022 Aug;269(8):4525-4534. doi: 10.1007/s00415-022-11039-5. Epub 2022 Mar 1.
PMID: 35229190BACKGROUNDGildir S, Tuzun EH, Eroglu G, Eker L. A randomized trial of trigger point dry needling versus sham needling for chronic tension-type headache. Medicine (Baltimore). 2019 Feb;98(8):e14520. doi: 10.1097/MD.0000000000014520.
PMID: 30813155BACKGROUNDPourahmadi M, Dommerholt J, Fernandez-de-Las-Penas C, Koes BW, Mohseni-Bandpei MA, Mansournia MA, Delavari S, Keshtkar A, Bahramian M. Dry Needling for the Treatment of Tension-Type, Cervicogenic, or Migraine Headaches: A Systematic Review and Meta-Analysis. Phys Ther. 2021 May 4;101(5):pzab068. doi: 10.1093/ptj/pzab068.
PMID: 33609358BACKGROUNDEspi-Lopez GV, Gomez-Conesa A. Efficacy of manual and manipulative therapy in the perception of pain and cervical motion in patients with tension-type headache: a randomized, controlled clinical trial. J Chiropr Med. 2014 Mar;13(1):4-13. doi: 10.1016/j.jcm.2014.01.004.
PMID: 24711779BACKGROUNDAnheyer D, Leach MJ, Klose P, Dobos G, Cramer H. Mindfulness-based stress reduction for treating chronic headache: A systematic review and meta-analysis. Cephalalgia. 2019 Apr;39(4):544-555. doi: 10.1177/0333102418781795. Epub 2018 Jun 4.
PMID: 29863407BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Antonio Manuel Fernández Pérez, Pt, phD
Department of Physiotherapy, Faculty of Health Sciences, University of Granada
- STUDY CHAIR
Dulce María Romero Ayuso, PhD
Department of Physiotherapy, Faculty of Health Sciences, University of Granada
- STUDY DIRECTOR
JIHANE Boudount El Kadaoui, PT, DO, PhD(c)
Doctoral Program in Clinical Medicine and Public Health, University of Granada, Spain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be blinded to their group assignment to minimize expectation bias. Outcome assessors will also be blinded to intervention allocation. Therapists and investigators will not be blinded due to the nature of the interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 16, 2025
First Posted
November 21, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. All data will be anonymized and handled in accordance with the General Data Protection Regulation (EU 2016/679) and Spanish Organic Law 3/2018 on Data Protection. Only aggregated and de-identified results will be published in peer-reviewed journals or presented at scientific conferences. No transfer of raw data to third parties is planned, and data access will remain restricted to the research team at the University of Granada under the supervision of the local Biomedical Research Ethics Committee of Andalusia.